MedTrace Logo

Microporous Polysaccharide Hemospheres Epistaxis

NCT02466464 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2017-01-26

No results posted yet for this study

Summary

The purpose of this study is to compare a new treatment for nosebleeds to the treatment that has been used for many years.

Conditions

Interventions

DEVICE

Microporous Polysaccharide Hemospheres

Two grams of Arista powder will be placed into the nose followed by four minutes of pressure and a moustache dressing.

DEVICE

Nasal Tampon

8 cm of Merocel dressing will be placed into one or both sides of your nose for the next three to five days and will then be removed by the physician.

Sponsors & Collaborators

  • Emory University

    lead OTHER

Principal Investigators

  • Oswaldo Henriquez Ajami, MD · Emory University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-01
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02466464 on ClinicalTrials.gov